Delivra Competitors

OTC Stocks . USA . 
Stock . Delivra Health Brands
DHBUF Stock  USD 0.01  0.0003  2.65%   
Delivra Health Brands competes with Avicanna, Goodness Growth, and C21 Investments; as well as few others. The company classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. Analyzing Delivra Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Delivra Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Delivra Health Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Delivra Health competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Delivra Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.019.29
Details
Intrinsic
Valuation
LowRealHigh
0.000.019.29
Details

Delivra Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Delivra Health and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Delivra and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Delivra Health Brands does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
DLTNF
+ 1.0
RAMMF
SSIC
+ 0.66
CVGRF
AVCNF
+ 0.62
ETRGF
LOWLF
+ 0.61
SSIC
LOWLF
+ 0.18
CVGRF
LOWLF
+ 0.07
CRFTF
  
High negative correlations   
DLTNF
- 1.0
BHHKF
BHHKF
- 1.0
RAMMF
ETRGF
- 0.57
CVGRF
SSIC
- 0.54
AVCNF
SSIC
- 0.51
ETRGF
CRFTF
- 0.51
CVGRF

Risk-Adjusted Indicators

There is a big difference between Delivra OTC Stock performing well and Delivra Health OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Delivra Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
RAMMF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
BHHKF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
SPBBF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
CVGRF  3.90  0.99  0.00  1.17  0.00 
 0.00 
 0.00 
 0.00 
 95.65 
CRFTF  3.65 (1.81) 0.00  1.23  0.00 
 0.00 
 0.00 
 0.00 
 99.00 
ETRGF  11.58  1.70  0.11 (1.62) 12.25 
(17.54)
 43.59 
(25.93)
 112.65 
AVCNF  5.09  0.22  0.01  8.40  6.09 
(11.43)
 19.05 
(13.33)
 45.00 
SSIC  1.02  0.24  0.14 (0.34) 0.80 
(1.39)
 3.36 
(1.54)
 8.15 
LOWLF  16.18  2.09  0.10 (0.84) 14.37 
(27.39)
 50.00 
(22.22)
 115.62 
DLTNF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
All Fundamental Data

Delivra Health Competitive Analysis

The better you understand Delivra Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Delivra Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Delivra Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
DHBUF RAMMF BHHKF CVGRF CRFTF ETRGF AVCNF SSIC LOWLF DLTNF
 2.65 
 0.01 
Delivra
 0.00 
 0.06 
RAMM
 0.00 
 0 
Benchmark
 61.48 
 0.01 
City
 0.00 
 0.0001 
CRFTF
 8.45 
 0.01 
Entourage
 7.41 
 0.25 
Avicanna
 0.62 
 12.80 
Silver
 9.09 
 0.01 
Lowell
 0.00 
 0.01 
Delta
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Very steady
Out of control
Out of control
Out of control
Out of control
Not too volatile
Out of control
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Modest
Very Weak
Modest
Insignificant
OK
Insignificant
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Quite High
Dangerous
Very High
Low
Quite High
Average
Low
Dangerous
Quite High
Above Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Not Rated
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Not Rated
Strong Sell
Strong Sell
Current Ratio
1.02
9.18
0.13
0.24
0.6
3.6
0.9
111.63
2.25
1.41
Net Asset
11.59 M
59.71 M
6.52 M
5.1 M
N/A
144.22 M
22.3 M
88.58 M
137.38 M
74.78 M
Profit Margin
-0.77
-1.76
N/A
N/A
N/A
-1.86
N/A
0.45
-0.48
-0.33
EBITDA
(4.25 M)
(6.36 M)
(12.61 M)
(3.2 M)
(1.65 M)
(61.41 M)
(15.13 M)
7.34 M
(15.74 M)
(1.17 M)
Operating Margin
-0.66
-1.89
-18.13
-15.8
-4.64
-0.96
-2.11
0.67
-0.38
-0.25
Current Valuation
4.15 M
1.85 M
6.45 M
4.99 M
1.34 M
89.84 M
20.15 M
32.12 M
75.28 M
54.59 M
Price To Book
1.66
0.18
0.88
88.0
0.78
2.56
9.32
0.78
0.21
0.68
Retained Earnings
N/A
N/A
N/A
N/A
N/A
N/A
N/A
449.27 K
N/A
N/A
Beta
1.78
-0.75
0.99
2.1
1.45
1.86
1.94
0.28
1.97
1.09
Number Of Employees
8
2
5
2
5
10
124
5
201
210
Shares Outstanding
252.62 M
122.4 M
58.99 M
321.26 M
2.28 M
306.74 M
74.52 M
6.21 M
100.61 M
149.01 M
Cash Flow From Operations
(4.44 M)
(3.82 M)
(2.73 M)
(117.53 K)
(1.43 M)
(30.01 M)
(11.66 M)
7.98 M
(26.05 M)
(775.48 K)
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.094
N/A
N/A
Total Debt
1.67 M
8.69 K
8.08 M
40 K
1.61 M
4.57 M
415.83 K
3.01 M
22.9 M
2.48 M
Return On Equity
-1.01
-0.12
-11.56
-4.21
-26.05
-3.71
-1.69
0.0641
-0.34
-0.91
Z Score
1.2
N/A
-3.3
19.2
N/A
0.6
33.0
N/A
N/A
1.8
Return On Asset
-0.22
-0.0789
-0.21
-0.28
-0.19
-0.19
-0.22
0.0562
-0.0831
-0.11
Book Value Per Share
0.012
0.41
0.015
-0.003
-0.6
-0.044
0.038
13.56
0.51
0.12
Number Of Shares Shorted
N/A
N/A
N/A
N/A
N/A
N/A
N/A
9.78 K
N/A
N/A
Total Asset
11.59 M
59.71 M
6.52 M
5.1 M
N/A
144.22 M
22.3 M
88.58 M
137.38 M
74.78 M
Debt To Equity
0.38
N/A
1.5
1.1
3.21
N/A
0.31
N/A
0.95
3.5
Short Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
4.63
N/A
N/A
Target Price
N/A
N/A
N/A
N/A
N/A
N/A
N/A
8.8
1.2
N/A
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.98
N/A
N/A
Shares Owned By Institutions
N/A
0.89
N/A
N/A
N/A
N/A
N/A
76.19
5.1
N/A
Market Capitalization
3.71 M
15.16 M
1.75 M
1.29 M
1.21 M
6.61 M
22.99 M
66.13 M
7.59 M
8.48 M
Price To Earning
N/A
N/A
N/A
N/A
0.01
N/A
N/A
N/A
N/A
N/A
Price To Sales
0.48
4.04
4.61
13.52
2.45
0.19
4.51
5.32
0.24
0.13
Net Income
(7.01 M)
(7.11 M)
(10.06 M)
(4.62 M)
(16.71 M)
(78.94 M)
(16.77 M)
7.34 M
(24.68 M)
(11.18 M)
Earnings Per Share
N/A
-0.051
-0.38
-0.013
17.17
-0.23
-0.26
0.9
-0.21
-0.085
Shares Owned By Insiders
21.99
34.88
N/A
34.94
0.84
20.11
22.52
0.43
39.62
37.09
Revenue
8.14 M
4.12 M
1.01 M
N/A
360.69 K
42.27 M
3.27 M
11.72 M
53.72 M
62.29 M
Cash And Equivalents
1.67 M
12.79 M
273.03 K
9.45 K
4.51 K
14.15 M
685.94 K
60.62 M
2.75 M
13.49 M
Cash Per Share
0.01
0.1
N/A
N/A
N/A
0.05
0.01
9.75
0.03
0.11
Gross Profit
2.6 M
(37.32 K)
(62.33 K)
N/A
35.26 K
(11.71 M)
2.83 M
5.38 M
2.48 M
17.32 M
Day Typical Price
0.011
0.055
0.0034
0.0048
1.0E-4
0.008
0.25
12.83
0.0117
0.008
Accumulation Distribution
N/A
N/A
N/A
0.25
N/A
0.14
N/A
0.0062
0.33
N/A
Market Facilitation Index
N/A
N/A
N/A
0.0013
N/A
0.0012
N/A
0.08
0.005
N/A
Daily Balance Of Power
(9,223,372,036,855)
0.0
0.0
(6.38)
0.0
0.5
(9,223,372,036,855)
(1.00)
(0.20)
0.0
Period Momentum Indicator
(0.0003)
N/A
N/A
(0.01)
N/A
6.0E-4
(0.02)
(0.08)
(0)
N/A
Rate Of Daily Change
0.97
1.0
1.0
0.39
1.0
1.08
0.93
0.99
0.91
1.0
Day Median Price
0.011
0.055
0.0034
0.0046
1.0E-4
0.0081
0.25
12.84
0.0125
0.008
Price Action Indicator
(0.0001)
N/A
N/A
(0)
N/A
(0.0001)
(0.01)
(0.08)
(0)
N/A
Coefficient Of Variation
(1,534)
N/A
N/A
1399.46
(665.09)
1169.66
3724.12
695.12
1153.33
N/A
Mean Deviation
5.98
N/A
N/A
3.9
3.65
11.58
5.09
1.02
16.18
N/A
Jensen Alpha
(0.54)
N/A
N/A
0.9912
(1.81)
1.7
0.2152
0.2412
2.09
N/A
Total Risk Alpha
(1.35)
N/A
N/A
(0.13)
(2.89)
0.1036
(0.46)
0.0865
0.1503
N/A
Sortino Ratio
N/A
N/A
N/A
N/A
N/A
0.1074
0.0147
0.1353
0.1046
N/A
Downside Variance
N/A
N/A
N/A
N/A
N/A
217.44
116.8
1.2
327.71
N/A
Standard Deviation
9.26
N/A
N/A
14.73
12.53
19.32
8.44
1.5
22.62
N/A
Kurtosis
7.46
N/A
N/A
31.54
57.89
4.46
2.15
4.38
2.71
N/A
Potential Upside
10.46
N/A
N/A
N/A
N/A
43.59
19.05
3.36
50.0
N/A
Treynor Ratio
0.4791
N/A
N/A
1.17
1.23
(1.62)
8.4
(0.34)
(0.84)
N/A
Maximum Drawdown
70.75
N/A
N/A
95.65
99.0
112.65
45.0
8.15
115.62
N/A
Variance
85.72
N/A
N/A
216.95
157.08
373.28
71.29
2.26
511.69
N/A
Market Risk Adjusted Performance
0.4891
N/A
N/A
1.18
1.24
(1.61)
8.41
(0.33)
(0.83)
N/A
Risk Adjusted Performance
(0.04)
N/A
N/A
0.0613
(0.1)
0.0716
0.0286
0.1094
0.0725
N/A
Skewness
1.24
N/A
N/A
3.19
(7.48)
1.52
0.6328
1.38
1.27
N/A
Semi Deviation
N/A
N/A
N/A
N/A
N/A
12.25
6.09
0.7999
14.37
N/A
Information Ratio
(0.07)
N/A
N/A
0.0669
(0.16)
0.082
0.0188
0.0988
0.0837
N/A
Value At Risk
(13.87)
N/A
N/A
N/A
N/A
(25.93)
(13.33)
(1.54)
(22.22)
N/A
Expected Short fall
N/A
N/A
N/A
N/A
N/A
(17.54)
(11.43)
(1.39)
(27.39)
N/A
Downside Deviation
N/A
N/A
N/A
N/A
N/A
14.75
10.81
1.1
18.1
N/A
Semi Variance
N/A
N/A
N/A
N/A
N/A
150.07
37.15
0.6399
206.54
N/A

Delivra Health Competition Performance Charts

Five steps to successful analysis of Delivra Health Competition

Delivra Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Delivra Health Brands in relation to its competition. Delivra Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Delivra Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Delivra Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Delivra Health Brands, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Delivra Health position

In addition to having Delivra Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Shipbuilding Railroad Equipment Thematic Idea Now

Shipbuilding Railroad Equipment
Shipbuilding Railroad Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipbuilding Railroad Equipment theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipbuilding Railroad Equipment Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Delivra OTC Stock

Delivra Health financial ratios help investors to determine whether Delivra OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Delivra with respect to the benefits of owning Delivra Health security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY